logo

Cel-Sci Corp. (CVM)



Trade CVM now with
  Date
  Headline
3/24/2020 9:29:13 AM CEL-SCI Increases Previously Announced Bought Deal To $7.7 Mln
3/9/2020 7:58:00 AM CEL-SCI Initiates Development Of Immunotherapy To Treat COVID-19 Coronavirus Infection
2/10/2020 8:08:35 AM CEL-SCI Q1 Net Loss $5.5 Mln Vs Net Income $1.2 Mln Last Year
12/24/2019 7:17:46 AM CEL-SCI Prices Public Offering With Gross Proceeds Of $5.5 Mln
12/23/2019 4:08:14 PM CEL-SCI Announces Proposed Underwritten Public Offering Of Common Stock
10/15/2019 8:40:34 AM CEL-SCI Reports Recent Data Review By IDMC For Phase 3 Head & Neck Cancer Study
7/8/2019 9:06:24 AM CEL-SCI Collaborators Presents Data For New Vaccine For Rheumatoid Arthritis
6/10/2019 9:17:06 AM CEL-SCI To Join The Broad-market Russell 3000 Index
1/23/2019 9:21:37 AM U.S. Patent Office Issues CEL-SCI Two Patents For Its LEAPS Vaccine Platform Technology
1/15/2019 8:08:29 AM CEL-SCI Regains Full Listing Compliance With NYSE American
  
 
>